Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors

Core Insights - Assertio Holdings, Inc. has appointed Mark Reisenauer as an independent director to its Board of Directors, who will also serve on the Compensation Committee [1][2] - Reisenauer brings over 30 years of experience in oncology and hematology, having previously held significant roles at Astellas Pharmaceuticals, Micromet, and Abbott Laboratories [2][3] - The company aims to enhance its commercial platform and explore new pharmaceutical assets under Reisenauer's leadership [2] Company Overview - Assertio is a commercial pharmaceutical company that offers differentiated products to patients, built through acquisition or licensing of approved products [3] - The company has comprehensive commercial capabilities, including marketing through a sales force and non-personal promotion, market access through payor contracting, and trade and distribution [3]